Changing Faces of ADHD Diagnosis For a long time, ADHD was predominantly associated with boisterous boys. However, recent trends reveal a broader understanding. Today, women are increasingly seeking diagnosis, reshaping longstanding stereotypes. The Rise of Female ADHD Diagnosis Statistics show a significant gap in ADHD diagnoses between boys and girls. A decade ago, four to … Read more
The Surge in ADHD Medication Prescriptions: A Deeper Look The last five years have seen an 87% increase in ADHD medication prescriptions, with young people aged 16 to 24 taking the lead. This unprecedented rise underscores the growing demand for mental health services, a phenomenon that has caught the attention of ADHD Ireland and the … Read more
Innovating Autism Diagnoses: The CAMI Tool’s Role in Transforming Healthcare A new tool called Computerized Assessment of Motor Imitation (CAMI) could revolutionize the way healthcare professionals diagnose Autism Spectrum Disorder (ASD). Developed by researchers at Nottingham Trent University and the Kennedy Krieger Institute, CAMI’s innovative use of motion-tracking technology marks a significant step forward in … Read more
The Rise in ADHD Diagnoses: Trends and Implications In recent years, there’s been a notable increase in adults diagnosed with ADHD. With more than 15 million U.S. adults now diagnosed, understanding the shifting landscape of ADHD is crucial for those affected and the healthcare providers who support them. Current Trends in ADHD Diagnosis and Treatment … Read more
The Hidden Health Challenges of Adults with ADHD Recent studies have revealed a startling impact of Attention Deficit Hyperactivity Disorder (ADHD) on life expectancy in adults. A comprehensive analysis in the UK highlights that adults with ADHD tend to die earlier than those without the diagnosis, raising significant public health concerns. Understanding the ADHD Life … Read more
The Future of Cancer Treatment: Spotlight on New Medicines The landscape of cancer treatment is rapidly evolving, with pharmaceutical breakthroughs promising to enhance patient outcomes dramatically. Pharmac’s recent proposals to fund six new medicines for cancer hint at a transformative future for oncology care. These include dual immune therapies like nivolumab (Opdivo) and ipilimumab (Yervoy) … Read more